✦ LIBER ✦

Cost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox–Gastaut Syndrome in the United Kingdom

✍ Scribed by Lara Verdian; Yunni Yi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND10 COST EFFECTIVENESS ANALYSES OF RUF

✍ Benedict Á; PL Dale; G MacLaine; L Verdian 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Cost-Utility Analysis of Lisdexamfetamin

✍ Zimovetz, E.; Beard, S.M.; Hodgkins, P.; Bischof, M.; Mauskopf, J.A.; Setyawan, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

A Cost-Utility Analysis of Lighterlife T

✍ Lewis, L.; Taylor, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

A Cost-Utility Analysis of Everolimus Pl

✍ Taylor, M.; Lewis, L.; Vieira, J.; Chandiwana, D. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PUK10 Cost-Effectiveness Analysis of Sol

✍ W.M. Hart; V. Munro; P. Retsa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN46 A COST UTILITY ANALYSIS OF MAINTEN

✍ U Geary; G Lewis; R Aultman; M Aristides 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB